Cargando…

Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity

BACKGROUND: Controlled clinical trials of health care interventions are either explanatory or pragmatic. Explanatory trials test whether an intervention is efficacious; that is, whether it can have a beneficial effect in an ideal situation. Pragmatic trials measure effectiveness; they measure the de...

Descripción completa

Detalles Bibliográficos
Autores principales: Godwin, Marshall, Ruhland, Lucia, Casson, Ian, MacDonald, Susan, Delva, Dianne, Birtwhistle, Richard, Lam, Miu, Seguin, Rachelle
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC317298/
https://www.ncbi.nlm.nih.gov/pubmed/14690550
http://dx.doi.org/10.1186/1471-2288-3-28
_version_ 1782121136946937856
author Godwin, Marshall
Ruhland, Lucia
Casson, Ian
MacDonald, Susan
Delva, Dianne
Birtwhistle, Richard
Lam, Miu
Seguin, Rachelle
author_facet Godwin, Marshall
Ruhland, Lucia
Casson, Ian
MacDonald, Susan
Delva, Dianne
Birtwhistle, Richard
Lam, Miu
Seguin, Rachelle
author_sort Godwin, Marshall
collection PubMed
description BACKGROUND: Controlled clinical trials of health care interventions are either explanatory or pragmatic. Explanatory trials test whether an intervention is efficacious; that is, whether it can have a beneficial effect in an ideal situation. Pragmatic trials measure effectiveness; they measure the degree of beneficial effect in real clinical practice. In pragmatic trials, a balance between external validity (generalizability of the results) and internal validity (reliability or accuracy of the results) needs to be achieved. The explanatory trial seeks to maximize the internal validity by assuring rigorous control of all variables other than the intervention. The pragmatic trial seeks to maximize external validity to ensure that the results can be generalized. However the danger of pragmatic trials is that internal validity may be overly compromised in the effort to ensure generalizability. We are conducting two pragmatic randomized controlled trials on interventions in the management of hypertension in primary care. We describe the design of the trials and the steps taken to deal with the competing demands of external and internal validity. DISCUSSION: External validity is maximized by having few exclusion criteria and by allowing flexibility in the interpretation of the intervention and in management decisions. Internal validity is maximized by decreasing contamination bias through cluster randomization, and decreasing observer and assessment bias, in these non-blinded trials, through baseline data collection prior to randomization, automating the outcomes assessment with 24 hour ambulatory blood pressure monitors, and blinding the data analysis. SUMMARY: Clinical trials conducted in community practices present investigators with difficult methodological choices related to maintaining a balance between internal validity (reliability of the results) and external validity (generalizability). The attempt to achieve methodological purity can result in clinically meaningless results, while attempting to achieve full generalizability can result in invalid and unreliable results. Achieving a creative tension between the two is crucial.
format Text
id pubmed-317298
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-3172982004-01-23 Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity Godwin, Marshall Ruhland, Lucia Casson, Ian MacDonald, Susan Delva, Dianne Birtwhistle, Richard Lam, Miu Seguin, Rachelle BMC Med Res Methodol Debate BACKGROUND: Controlled clinical trials of health care interventions are either explanatory or pragmatic. Explanatory trials test whether an intervention is efficacious; that is, whether it can have a beneficial effect in an ideal situation. Pragmatic trials measure effectiveness; they measure the degree of beneficial effect in real clinical practice. In pragmatic trials, a balance between external validity (generalizability of the results) and internal validity (reliability or accuracy of the results) needs to be achieved. The explanatory trial seeks to maximize the internal validity by assuring rigorous control of all variables other than the intervention. The pragmatic trial seeks to maximize external validity to ensure that the results can be generalized. However the danger of pragmatic trials is that internal validity may be overly compromised in the effort to ensure generalizability. We are conducting two pragmatic randomized controlled trials on interventions in the management of hypertension in primary care. We describe the design of the trials and the steps taken to deal with the competing demands of external and internal validity. DISCUSSION: External validity is maximized by having few exclusion criteria and by allowing flexibility in the interpretation of the intervention and in management decisions. Internal validity is maximized by decreasing contamination bias through cluster randomization, and decreasing observer and assessment bias, in these non-blinded trials, through baseline data collection prior to randomization, automating the outcomes assessment with 24 hour ambulatory blood pressure monitors, and blinding the data analysis. SUMMARY: Clinical trials conducted in community practices present investigators with difficult methodological choices related to maintaining a balance between internal validity (reliability of the results) and external validity (generalizability). The attempt to achieve methodological purity can result in clinically meaningless results, while attempting to achieve full generalizability can result in invalid and unreliable results. Achieving a creative tension between the two is crucial. BioMed Central 2003-12-22 /pmc/articles/PMC317298/ /pubmed/14690550 http://dx.doi.org/10.1186/1471-2288-3-28 Text en Copyright © 2003 Godwin et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Debate
Godwin, Marshall
Ruhland, Lucia
Casson, Ian
MacDonald, Susan
Delva, Dianne
Birtwhistle, Richard
Lam, Miu
Seguin, Rachelle
Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity
title Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity
title_full Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity
title_fullStr Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity
title_full_unstemmed Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity
title_short Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity
title_sort pragmatic controlled clinical trials in primary care: the struggle between external and internal validity
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC317298/
https://www.ncbi.nlm.nih.gov/pubmed/14690550
http://dx.doi.org/10.1186/1471-2288-3-28
work_keys_str_mv AT godwinmarshall pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity
AT ruhlandlucia pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity
AT cassonian pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity
AT macdonaldsusan pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity
AT delvadianne pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity
AT birtwhistlerichard pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity
AT lammiu pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity
AT seguinrachelle pragmaticcontrolledclinicaltrialsinprimarycarethestrugglebetweenexternalandinternalvalidity